SEC Form 4 · accession 0001209191-15-010384
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katherine A High
Officer — See Remarks · Director
Period of report
Feb 4, 2015
Accepted (ET)
Feb 6, 2015 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 4, 2015 | P | 700 | $23.00 | A | 700 | I | See footnote |
| Common Stock | holding | — | — | — | 340,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the spouse of the reporting person.
Remarks
President and Chief Technology Officer